Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Non-Current Assets: 2009-2024

Historic Non-Current Assets for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $3.5 billion.

  • UNITED THERAPEUTICS's Non-Current Assets rose 23.52% to $3.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 billion, marking a year-over-year increase of 23.52%. This contributed to the annual value of $3.5 billion for FY2024, which is 3.48% down from last year.
  • According to the latest figures from FY2024, UNITED THERAPEUTICS's Non-Current Assets is $3.5 billion, which was down 3.48% from $3.6 billion recorded in FY2023.
  • Over the past 5 years, UNITED THERAPEUTICS's Non-Current Assets peaked at $3.6 billion during FY2023, and registered a low of $2.4 billion during FY2020.
  • Its 3-year average for Non-Current Assets is $3.3 billion, with a median of $3.5 billion in 2024.
  • In the last 5 years, UNITED THERAPEUTICS's Non-Current Assets fell by 6.37% in 2022 and then soared by 35.73% in 2023.
  • Yearly analysis of 5 years shows UNITED THERAPEUTICS's Non-Current Assets stood at $2.4 billion in 2020, then grew by 16.25% to $2.8 billion in 2021, then fell by 6.37% to $2.7 billion in 2022, then soared by 35.73% to $3.6 billion in 2023, then dropped by 3.48% to $3.5 billion in 2024.